Alzheimer's Research Charity is a UK-based charity, registered with the UK Charity Commission , as The Campaign for Alzheimer's Research in Europe. We support activities both within the UK and in collaboration with Europe..
We were founded in 1999 when several trustees of the former Alzheimer's Research Trust sought to refocus the charity's commitment to supporting research into the understanding and treatment of Alzheimer's disease.
Alzheimer's Research Charity is guided exclusively by supporting the best scientists and best academic science throughout Europe,
Alzheimer's Research Charity also supports academic meetings to encourage scientific exchange and collaboration between the leading research centres and teams throughout Europe.
Contact us to give your support or to seek advice on our funding streams.
Dr. Sarah-Jane Richards
SECRETARY & TRUSTEE
Sarah-Jane founded the charity in 1999 with Mrs Pat Naughton and Dr Andrea Thorpe.
She is trained as a molecular neurobiologist, directing a research team at the Univeristy of Cambridge until 2000. She then retrained as a solicitor and is now a specialist in biomedical law.
Prof Konrad Beyreuter
CHAIRMAN & TRUSTEE
Konrad Beyreuther is Professor and head of the Institute of Genetics at Heidelberg University, Germany,
With Colin Masters he is the co-discoverer of the beta-A4 amyloid peptide at the heart of the principal neuropathology of Alzheimer's disease.
Mrs Pat Naughton
Pat co-founded the charity with Sarah-Jane in 1979,
She co-ordinates major C.A.R.E. fund-raising activities .
Prof. David Mann
David Mann is Professor of Human Neuropathology at Manchester University and is a world expert on the neuropathology of Alzheimer's disease.
Dr Andrea Thorpe
Andrea Thorpe is a molecular biologist witha long-standing research interest in the molecular biology of Alzheimer's disease and Down syndrome.
Prof Colin Masters
Colin Masters is Professor and head of the Mental Health Research Institute at the Florey Institute and University of Melbourne Australia. He is co-discoverer of the beta-A4 amyloid peptide at the heart of the principal neuropathology of Alzheimer's disease.
Prof. Stephen Dunnett
Stephen Dunnett is Professor of Neuroscience at Cardiff University, and a specialist in animal models and cell therapy for neurodegenerative disease